[Federal Register: August 5, 2004 (Volume 69, Number 150)]
[Notices]               
[Page 47450]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05au04-73]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2004N-0246]

 
Agency Emergency Processing Under Office of Management and Budget 
Review; Experimental Study of Petitioned Health Claims on Glucosamine 
and Chondroitin Sulfate; Withdrawal

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; withdrawal.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is withdrawing a notice 
that published in the Federal Register of June 3, 2004 (69 FR 31395).

DATES: This notice is withdrawn on August 5, 2004.

FOR FURTHER INFORMATION CONTACT: May D. Nelson, Center for Food Safety 
and Applied Nutrition (HFS-024), Food and Drug Administration, 5100 
Paint Branch Pkwy., College Park, MD 20740, 301-436-1722.

SUPPLEMENTARY INFORMATION: In the Federal Register of June 3, 2004, FDA 
published a notice informing interested parties that the proposed 
collection of information entitled ``Experimental Study of Petitioned 
Health Claims on Glucosamine and Chondroitin Sulfate'' had been 
submitted to the Office of Management and Budget (OMB) for emergency 
processing under section 3507(j) of the Paperwork Reduction Act of 1995 
(44 U.S.C. 3507(j) and 5 CFR 1320.13). The notice contains a number of 
errors. In addition, we are reevaluating the design and objective of 
the study. Therefore, we are withdrawing both the notice itself and the 
request for OMB approval of the proposed collection of information.

    Dated: July 29, 2004.
William K. Hubbard,
Associate Commissioner for Policy and Planning.
[FR Doc. 04-17877 Filed 8-4-04; 8:45 am]

BILLING CODE 4160-01-S